Peiyang Mao, Xin Tian, Yinxia Zhan, Feng Gao, Xiangyu Tan, Hongfan Yu, Xiaobo Du, Jie Li, Gang Feng, Jingyu Zhang, Qiuling Shi
{"title":"Pain and Its Treatment Among Outpatients with Malignant Tumors in China.","authors":"Peiyang Mao, Xin Tian, Yinxia Zhan, Feng Gao, Xiangyu Tan, Hongfan Yu, Xiaobo Du, Jie Li, Gang Feng, Jingyu Zhang, Qiuling Shi","doi":"10.2147/CMAR.S532474","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pain is common among patients with malignant tumors. It significantly impacts quality of life, yet over 80% of advanced cancer patients lack adequate pain management. Despite improvements in China's pain management program, challenges remain, especially for older adults and outpatient care.</p><p><strong>Methods: </strong>We evaluated pain intensity management adequacy using a 0-10 numerical rating scale (NRS), and Pain Management Index (PMI) at an outpatient oncology clinic. Differences and changes in pain levels were statistically analyzed using <i>t</i>-test, rank-sum, and chi-square tests. Factors associated with inadequate pain management were identified using multivariate logistic regression.</p><p><strong>Results: </strong>Among 589 participants, 45.41% scored moderate to severe pain ≥ 4, and 81.32% experienced inadequate pain management (PMI < 0). Pain was more severe among older, than younger patients (4.15 ± 2.89 vs 3.65 ± 2.41, <i>P</i> < 0.001) and pain management was inadequate in older compared with younger patients (75.47% vs 89.87%). Undergoing targeted or immune adjuvant therapy (odds ratio [OR], 3.206; 95% confidence interval [CI], 1.538-6.684) and poor physical status (OR, 5.053; 95% CI, 2.023-12.622) emerged as significant risk factors for inadequate pain management.</p><p><strong>Conclusion: </strong>Pain management is challenging for patients aged ≥60 years. Therefore, tailored interventions are needed to enhance care quality.</p>","PeriodicalId":9479,"journal":{"name":"Cancer Management and Research","volume":"17 ","pages":"1843-1850"},"PeriodicalIF":2.6000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12407010/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Management and Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CMAR.S532474","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Pain is common among patients with malignant tumors. It significantly impacts quality of life, yet over 80% of advanced cancer patients lack adequate pain management. Despite improvements in China's pain management program, challenges remain, especially for older adults and outpatient care.
Methods: We evaluated pain intensity management adequacy using a 0-10 numerical rating scale (NRS), and Pain Management Index (PMI) at an outpatient oncology clinic. Differences and changes in pain levels were statistically analyzed using t-test, rank-sum, and chi-square tests. Factors associated with inadequate pain management were identified using multivariate logistic regression.
Results: Among 589 participants, 45.41% scored moderate to severe pain ≥ 4, and 81.32% experienced inadequate pain management (PMI < 0). Pain was more severe among older, than younger patients (4.15 ± 2.89 vs 3.65 ± 2.41, P < 0.001) and pain management was inadequate in older compared with younger patients (75.47% vs 89.87%). Undergoing targeted or immune adjuvant therapy (odds ratio [OR], 3.206; 95% confidence interval [CI], 1.538-6.684) and poor physical status (OR, 5.053; 95% CI, 2.023-12.622) emerged as significant risk factors for inadequate pain management.
Conclusion: Pain management is challenging for patients aged ≥60 years. Therefore, tailored interventions are needed to enhance care quality.
期刊介绍:
Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include:
◦Epidemiology, detection and screening
◦Cellular research and biomarkers
◦Identification of biotargets and agents with novel mechanisms of action
◦Optimal clinical use of existing anticancer agents, including combination therapies
◦Radiation and surgery
◦Palliative care
◦Patient adherence, quality of life, satisfaction
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.